NeuroPn Therapeutics is a biopharmaceutical company focused on the discovery and development of innovative therapies for neurodegenerative diseases with focus on painful peripheral neuropathy (PPN) and Parkinson's disease (PD).
Painful peripheral neuropathy remains a significant public health problem that leads to significant impairment in quality of life for suffering patients. At NeuroPn, we are developing innovative therapeutics that address underlying disease to block neuronal degeneration and stimulate endogenous analgesic pathways to provide effective pain relief without narcotic effects.
Our approach has also been validated in Parkinson’s Disease to yield novel agents that promote neuronal healing and deliver functional and symptomatic relief.
Strategic Partnerships - Our business strategy is to build risk shared partnerships to identify clinical candidates and establish early proof of concept